Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more
Episurf Medical AB (publ) (EPIS-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.244x
Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) has a cash flow conversion efficiency ratio of -0.244x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million) by net assets (Skr47.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Episurf Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Episurf Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Episurf Medical AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Episurf Medical AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arbe Robotics Ltd. Warrant
NASDAQ:ARBEW
|
-0.221x |
|
Sono Group N.V.
OTCQB:SEVCF
|
0.087x |
|
TFLM
OTCQB:TFLM
|
0.080x |
|
Bumi Benowo Sukses Sejahtera Pt
JK:BBSS
|
-0.003x |
|
Crosswood
PA:CROS
|
-0.020x |
|
Lupatech S.A
SA:LUPA3
|
-0.162x |
|
Nuintek Co.Ltd
KQ:012340
|
0.038x |
|
PT DFI Retail Nusantara Tbk
JK:HERO
|
0.026x |
Annual Cash Flow Conversion Efficiency for Episurf Medical AB (publ) (2010–2025)
The table below shows the annual cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr47.50 Million | Skr-55.30 Million | -1.164x | -36.64% |
| 2024-12-31 | Skr83.80 Million | Skr-71.40 Million | -0.852x | +15.10% |
| 2023-12-31 | Skr84.50 Million | Skr-84.80 Million | -1.004x | -156.59% |
| 2022-12-31 | Skr177.70 Million | Skr-69.50 Million | -0.391x | -65.62% |
| 2021-12-31 | Skr252.80 Million | Skr-59.70 Million | -0.236x | +26.01% |
| 2020-12-31 | Skr169.50 Million | Skr-54.10 Million | -0.319x | +77.68% |
| 2019-12-31 | Skr41.40 Million | Skr-59.20 Million | -1.430x | -22.49% |
| 2018-12-31 | Skr44.80 Million | Skr-52.30 Million | -1.167x | -62.75% |
| 2017-12-31 | Skr85.57 Million | Skr-61.38 Million | -0.717x | +37.73% |
| 2016-12-31 | Skr48.70 Million | Skr-56.10 Million | -1.152x | -232.91% |
| 2015-12-31 | Skr109.93 Million | Skr-38.04 Million | -0.346x | +57.54% |
| 2014-12-31 | Skr38.85 Million | Skr-31.66 Million | -0.815x | -182.71% |
| 2013-12-31 | Skr71.61 Million | Skr-20.64 Million | -0.288x | +53.27% |
| 2012-12-31 | Skr24.39 Million | Skr-15.05 Million | -0.617x | -664.38% |
| 2011-12-31 | Skr48.50 Million | Skr-3.91 Million | -0.081x | +60.69% |
| 2010-12-31 | Skr9.74 Million | Skr-2.00 Million | -0.205x | -- |